CT83 and breast cancer: As mentioned in the screening part, the expression of CT83 mRNA is significantly higher in Basal/TNBC tissues compared with other subtypes, and a similar trend was observed in the 57 breast cancer cell lines (including 17 TNBC cell lines) in which the expression of CT83 mRNA was measured (Table S2).